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Abstract Three sensitive, selective and reproducible stability-indicating methods are presented for
determination of nitazoxanide (NTZ), a new anti-protozoal drug, in presence of its degradation
products. Method A utilizes the ﬁrst derivative of ratio spectra spectrophotometry by measurement of
the amplitude at 364.4 nm using one of the degradation products as a divisor. Method B is a
chemometric-assisted spectrophotometry, where principal component regression (PCR) and partial
least squares (PLS) were applied. These two approaches were successfully applied to quantify NTZ in
presence of degradation products using the information included in the absorption spectra in the range
260–360 nm. Method C is based on the separation of NTZ from its degradation products followed by
densitometric measurement of the bands at 254 nm. The separation was carried out on silica gel 60F254,
using chloroform–methanol–ammonia solution–glacial acetic acid (95:5:1:1 by volume, pH¼5.80) as a
developing system. These methods are suitable as stability-indicating methods for the determination of
NTZ in presence of its degradation products either in bulk powder or in pharmaceutical formulations.
Statistical analysis of the results has been carried out revealing high accuracy and good precision.
& 2012 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.
1. Introduction
Nitazoxanide (NTZ), as shown in Fig. 1, is a nitrothiazole
benzamide compound that has a wide range of antimicrobial
activity against parasites and bacterial pathogens [1]. It is
chemically designated as N-(5-nitro-2-thiazolyl) salicylamide
acetate [2]. It is used for the treatment of cryptosporidiosis and
giardiasis in immuno-competent patients. It is absorbed from the
gastrointestinal tract following oral administration and is rapidly
hydrolyzed to an active desacetyl metabolite (tizoxanide) [3–6].
Nitazoxanide is not ofﬁcial in any Pharmacopoeia. Few
methods have been reported for the quantitative estimation of
NTZ, including spectrophotometric either alone or in
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Figure 1 Degradation pathway of nitazoxanide.
N.W. Ali et al.106combination [7–11], colorimetric [12–14] and liquid chromato-
graphic [15–23] methods.
Literature survey revealed different stability indicating
methods performed on NTZ, but up to our knowledge, no
data on the structure of degradation products were reported.
An exhaustive study on the stability of NTZ is demanding
as the current ICH guidelines requires that stability study
should be done using developed and validated stability-
indicating assay methods after stress testing on the drug under
a variety of conditions [24].
The aim of this work was to develop a comparative study of
recent, simple, sensitive, validated stability indicating methods
that are of lower cost than the reported HPLC method.
These methods include spectrophotometric, chemometric and
TLC-densitometric ones for the determination of NTZ in
presence of its three degradation products in pure form,
laboratory prepared mixtures and in its pharmaceutical
formulations.2. Experimental
2.1. Instruments A double beam UV/VIS spectrophotometer (Shimadzu,
Japan) model UV-1601 PC with a quartz cell of 1 cm path
length. The spectral band width is 2 nm and the wave-
length-scanning speed is 2800 nm/min. All data analysis
was performed using PLS-Toolbox 2.0 running under
MATLABs, version 6.5 [25]. TLC scanner 3 densitometer (Camag, Muttenz, Switzerland).
The following requirements are taken into consideration:
J Slit dimensions: 5 0.2 mm
J Scanning speed: 20 mm/s
J Spraying rate: 10 s/mL
J Data resolution: 100 mm/step
J Band width: 6 mm
J Result output: Chromatogram and integrated peak area
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syringe (Camag, Muttenz, Switzerland). An IR spectrophotometer (Shimadzu 435, Kyoto, Japan);
sampling was undertaken as potassium bromide disks. A mass spectrophotometer: MS-QB 1000 EX, Finnigan
Nat (USA). TLC aluminum plates (20 20 cm) coated with 0.25 mm
silica gel 60F254 (Merck, Germany). UV lamp with short wavelength 254 nm (USA).2.2. Samples
2.2.1. Pure standard
NTZ was kindly supplied from Copad Pharma Co., Cairo,
Egypt. Its purity was found to be 99.90%, according to a
reported HPLC method [23]. Salicylic acid was obtained from
El-Nasr Pharm. Co., Cairo, Egypt.
2.2.2. Pharmaceutical formulations Nit Cleans tablets (Batch No. 10005) are labeled to
contain 500 mg of NTZ manufactured by Western Phar-
maceutical Industries Co., El-Obour City, Egypt. Nitazods powder for oral suspension (Batch No. 92456)
is labeled to contain 100 mg/5 mL NTZ manufactured by
Sigma Pharmaceutical Industries Co. for Al Andalous
Medical Co., Cairo, Egypt. Cryptonazs powder for oral suspension (Batch No.
0906189) is labeled to contain 100 mg/5 mL NTZ manu-
factured by ADWIA Co. for Copad Pharma Co.,
Cairo, Egypt.2.2.3. Degraded sample
2.2.3.1. Preparation of degradation product in acid-stress
condition. The degradation product under acid stress condi-
tion was laboratory prepared by dissolving 100 mg of pure
NTZ in the least amount of methanol, reﬂuxing with 100 mL
of 1 M HCl solution for 3 h. Follow complete degradation of
NTZ by TLC plates of silica gel 60F254 using chloroform–
methanol–ammonia solution–glacial acetic acid (95:5:1:1 by
volume, pH¼5.80) as a developing system where the spot of
NTZ disappeared and one new spot appeared. Filter the
formed precipitate (Deg I), wash with distilled water
(4 30 mL), transfer to a ﬂat bottom dish and allow drying
at room temperature. Structure elucidation was conducted by
IR and mass spectroscopy.
2.2.3.2. Preparation of degradation products in alkaline-stress
condition. Reﬂux 100 mg of pure NTZ with 100 mL of 0.1 M
NaOH solution for 30 min. Follow degradation by TLC using
chloroform–methanol–ammonia solution–glacial acetic acid
(95:5:1:1 by volume, pH¼5.80) as a developing system. At
the beginning, a degradation product similar to that obtained
under acid stress condition appeared and then rapidly dis-
appeared followed by the formation of two new spots of the
ﬁnal degradation products. After complete degradation;
extract the solution several times (4 30 mL) with ether (to
obtain Deg II) and then neutralize the solution with 0.1 M HCl
solution and extract several times with ether (4 30 mL) (to
obtain Deg III). Evaporate the basic and acidic extracts. Theseparated degradation products were subjected to IR and mass
spectral analyses for subsequent identiﬁcation.
2.3. Chemicals and reagents
All chemicals used throughout this work were of analytical
grade and the solvents were of spectroscopic grade. Methanol (E.Merck, Germany).
 Sodium hydroxide (0.1 M aqueous solution) and hydro-
chloric acid (0.1 M and 1 M aqueous solutions) (El-Nasr
Pharmaceutical Chemicals Co., Abu-Zabaal, Cairo,
Egypt). Methanol, chloroform, ammonia solution (Speciﬁc grav-
ity 0.91, 33%) and glacial acetic acid (El-Nasr Pharma-
ceutical Chemicals Co., Abu-Zabaal, Cairo, Egypt).2.4. Standard solutions
2.4.1. Stock standard solutions of nitazoxanide and its
degradation products (1 mg/mL)
Weigh accurately 0.1 g of each of NTZ, Deg I, Deg II and
Deg III into four separate 100-mL volumetric ﬂasks, dissolve
in and dilute to the volume with methanol.
2.4.2. Working standard solutions of nitazoxanide and its
degradation products (100 mg/mL)
Transfer accurately 10 mL from NTZ, Deg I, Deg II and Deg
III stock solutions into four separate 100-mL volumetric
ﬂasks, complete to the mark with methanol to obtain
100 mg/mL working standard solutions.
2.5. Laboratory prepared mixtures
Transfer different aliquots of NTZ from its working standard
solution (100 mg/mL) and then add aliquots of its degradation
products, Deg I, Deg II and Deg III, from their respective
working standard solutions (100 mg/mL) to prepare mixtures
of different ratios of NTZ and its degradation products
containing 10%–90% of the degradation products.
2.6. Procedure
2.6.1. Spectral characteristics of nitazoxanide and its
degradation products
Transfer accurately and separately, aliquots equivalent to 10,
10, 5 and 5 mg from NTZ, Deg I, Deg II and Deg III working
solutions (100 mg/mL in methanol), respectively, into 10-mL
volumetric ﬂasks. Complete to the volume with methanol.
Record the absorption spectrum of each solution over the
range of 200–500 nm using methanol as a blank.
2.6.2. Construction of calibration graph for ﬁrst derivative of
ratio spectra spectrophotometric method (DD1)
Transfer accurately aliquots equivalent to 20–240 mg of NTZ
from its working standard solution (100 mg/mL) into a series
of 10-mL volumetric ﬂasks, complete to the volume with
methanol. Record the absorption spectra of NTZ concentra-
tions against methanol as a blank. Divide NTZ series by the
chosen divisor (5 mg/mL of Deg I). Record the ﬁrst derivative
of the obtained ratio spectra using scaling factor¼10 and
Figure 2 IR spectra of nitazoxanide (A), Deg I (tizoxanide) (B), 5-nitro-1,3-thiazol-2-amine (Deg II) (C) and salicylic acid (Deg III) (D).
N.W. Ali et al.108Dl¼4 nm. Record the peak amplitude at 364.4 nm and plot
against the corresponding concentrations of NTZ and then
compute the regression equation.
2.6.3. Chemometric methods
2.6.3.1. Construction of the training set. Prepare different
mixtures of NTZ, Deg I, Deg II and Deg III into a series of
10-mL volumetric ﬂasks. Transfer accurately aliquots equiva-
lent to 20–100, 10–50, 10–50 and 10–50 mg from Deg I, Deg II
and Deg III working solutions (100 mg/mL). Complete to the
volume with methanol. Record the absorbance of these
mixtures between 200–500 nm at 1 nm interval with respect
to a blank of methanol.
The composition of the samples was randomly designed
according to ﬁve level calibration design [26] in order to obtain
non-correlated concentration proﬁles and this calibration
design prepared to obey Beer’s law.
Initial developed models were found to have high spectral
residuals in the region below 260 and above 360 nm. As a
result this region was rejected.
2.6.3.2. Construction of the models. To build the PCR and
PLS models, feed the computer with the absorbance and
concentration matrices for the training set, use the training
set absorbance and concentration matrices together with
PLS-Toolbox 2.0 software for the calculations.
2.6.3.3. Selection of the optimum number of factors to build
the PCR and PLS models. To select the number of factors for
PLS and PCR methods, a cross-validation method, usingleave one out, was used [27]. Given a set of 21 calibration
samples, the PCR and PLS calibrations were performed on
20 samples, then the concentration of the sample left out
during calibration was predicted. This process was repeated
21 times until each calibration sample had been left-out once.
The predicted concentrations were then compared with the
known concentrations and the root mean square error of
cross validation (RMSECV) was calculated. The RMSECV
was calculated in the same manner each time, a new factor
was added to the model. The maximum number of factors
used to calculate the optimum RMSECV was selected to be
11 (half the number of samplesþ1) [28]. Visual inspection
was used for selecting the optimum number of factors. Upon
building the models mean center the data gave better results
for both PCR and PLS.
2.6.3.4. Construction of the validation set. Prepare different
twelve mixtures of NTZ, Deg I, Deg II and Deg III by
transferring different volumes of their working standard
solutions (100 mg/mL) into a series of 10-mL volumetric ﬂasks
and then complete to the volume with methanol. Apply the
developed models to predict the concentration of NTZ, Deg I,
Deg II and Deg III in each mixture.
2.6.4. Construction of calibration graph for
TLC-densitometric method
Into a set of 10-mL volumetric ﬂasks, transfer accurately
aliquots equivalent to 0.4–2.0 mg of NTZ from its standard
stock solution (1 mg/mL), then complete the volume with
methanol. Apply 10 mL of each solution to TLC plates as
Stability indicating methods for determination of nitazoxanide 109bands of 6 mm width using a Camag Linomat IV applicator.
Space the bands 5 mm from each other and 15 mm apart from
the bottom edge of the plate. Pre-saturate the chromato-
graphic chamber with the developing system for one hour and
develop the plate by ascending chromatography using
chloroform–methanol–ammonia solution–glacial acetic acid
(95:5:1:1 by volume, pH¼5.80) as a developing system to a
distance of 8 cm. Record the integrated peak areas using
scanning wavelength at 254 nm and construct the calibration
curve by plotting the integrated peak area versus the corre-
sponding concentration of NTZ and compute the regression
equation.2.6.5. Application to pharmaceutical formulationsi. Nit cleans tablets: Weigh, powder ﬁnely ten tablets of
Nit cleans and mix well. Transfer an accurately weighed
amount of the powder equivalent to 100 mg of NTZ into
250-mL beaker. Add 75 mL methanol, sonicate for
30 min, ﬁlter into 100-mL volumetric ﬂask, then wash
the residual powder with methanol and ﬁnally complete
the volume with methanol to obtain 1 mg/mL stock
solution. Make the appropriate dilution to obtain
100 mg/mL working solution using methanol. Proceed
according to the calibration procedure of each method
mentioned before and then calculate NTZ concentration
using the corresponding regression equation.ii. Nitazods and Cryptonazs oral suspensions: Transfer
5 mL of each suspension into two separate 250-mL
beakers. Then proceed as mentioned above to determine
the concentration of NTZ in each solution.iii. Standard addition technique: Add different known con-
centrations of pure NTZ to Nit cleans tablets powder
and Nitazods and Cryptonazs oral suspensions, then
proceed as mentioned before to calculate the concentra-
tions of NTZ using the proposed methods.Figure 3 Mass spectra of nitazoxanide (A), Deg I (tizoxanide)
(B) and 5-nitro-1,3-thiazol-2-amine (Deg II) (C).3. Results and discussion
The ICH guideline Q2(R1) on Stability Testing of New Drug
Substances suggests that the testing of those features, which
are susceptible to change during storage and are likely to
inﬂuence quality, safety and efﬁcacy, must be done by
validated stability indicating methods. Stress testing should
be carried out on a drug to establish its inherent stability
characteristics and to support the suitability of the proposed
analytical method. Up to our knowledge, the literature survey
revealed that none of the most recognized pharmacopoeias or
any journals includes this information regarding the stability
of nitazoxanide.
Nitazoxanide was subjected to acid, alkaline hydrolysis and
photo-degradation. Being ester, in acidic condition the drug
undergoes hydrolysis into its corresponding acid (Deg I, active
metabolite). The same product is formed ﬁrst under alkaline
condition, which then undergoes further degradation due to
cleavage of amide linkage giving two degradation products,
namely, 5-nitro-1,3-thiazol-2-amine (Deg II) and salicylic acid
(Deg III). Results of photo-degradation of the drug coincide
with acid degradation process.
Salicylic acid, one of the degradation products of NTZ, is a
mild irritant and its application to the skin may cause
dermatitis. It is readily absorbed through the skin andsymptoms of acute systemic salicylate poisoning have been
reported after excessive use; deaths have occurred, mainly in
children [1]. So, bad storage of NTZ may lead to the presence
of salicylic acid, as a result of degradation process, which
exposes the patient to toxicity. So it is essential to develop
analytical procedure, which will serve a reliable, accurate,
sensitive and stability indicating method for the determination
of NTZ in presence of its degradation products.
3.1. Elucidation of nitazoxanide degradation products
Nitazoxanide was subjected to hydrolysis under acid-stress
condition by reﬂuxing with 1 M HCl solution for 3 h giving
one degradation product (due to cleavage of ester bond). On the
other hand, when subjected to hydrolysis under alkaline-stress
condition with 0.1 M NaOH solution at room temperature, the
same product obtained under acid stress condition in addition to
two new degradation products were obtained, so that the
solution was heated for 30 min for complete degradation, giving
the ﬁnal two degradation products (due to the cleavage of amide
Figure 4 Zero order absorption spectra of 10 mg/mL of NTZ
(—), 10 mg/mL of Deg I (- - - - - -), 5 mg/mL of Deg II (-.-.-.) and
5 mg/mL of Deg III (yy) using methanol as a solvent.
Figure 5 First derivative of ratio spectra of 10 mg/mL of NTZ
(—), 10 mg/mL of Deg I (- - - - - -), 5 mg/mL of Deg II (-.-.-.) and
5 mg/mL of Deg III (yy) using 5 mg/mL of Deg I as a divisor
and methanol as a solvent.
Table 1 Concentration of mixtures of nitazoxanide,
Deg I, Deg II and Deg III used in the training and
validation sets.
Mixture no. Concentration (mg/mL)
NTZ Deg I Deg II Deg III
1 6 3 3 3
2 10 3 2 2
3 6 2 2 4
4 4 2 4 5
5 4 4 5 4
6 8 5 4 3
7 10 4 3 5
8 8 3 5 5
9 6 5 5 1
10 10 5 1 4
11 10 1 4 1
12 2 4 1 3
13 8 1 3 4
14 2 3 4 4
15 6 4 4 2
16 8 4 2 1
17 8 2 1 2
18 4 1 2 3
19 2 2 3 1
20 4 3 1 1
21 6 1 1 5
22 2 1 5 2
23 2 5 2 5
24 10 2 5 3
25 4 5 3 2
26 10 3 2 5
27 6 2 5 2
28 4 5 2 4
29 10 2 4 4
30 4 4 4 3
31 8 4 3 5
32 8 3 5 4
33 6 5 4 5
The concentrations of mixtures used in the validation set are
given in bold font.
N.W. Ali et al.110bond). Degradation pathway of NTZ is shown in Fig. 1. The
degradation products were isolated as mentioned before and
characterized by MS- and IR-spectrometry.3.1.1. Spectral changes
The IR spectrum of intact NTZ shows characteristic bands at
1771 and 1617 cm1 corresponding to carbonyl groups (C¼O)
of ester and amide linkages. This band of carbonyl group of
amide linkage still present in IR spectrum of degradation
product results from acid stress condition at 1671 cm1, while
the other carbonyl band of ester linkage that disappeared with
appearance of a new broad band at 3256–2578 cm1 indicates
presence of (–OH) hydroxyl group, which conﬁrms the
suggested degradation product (Deg I). While degradation
under alkaline stress condition gives two products that do not
have either bands of carbonyl ester group or amide linkage
functional group.
The IR spectrum of ﬁrst degradation product that was
extracted from alkaline medium has a forked band at 3396
and 3189 cm1 that indicates presence of (–NH2) primary
amine group, which conﬁrms the expected degradation product
(Deg II), while the IR spectrum of second degradation product
that was extracted after acidiﬁcation shows a band at
1662 cm1 that indicates presence of carbonyl group and abroad band at 3236–2597 cm1 indicate presence of (–OH)
hydroxyl group (Deg III), as shown in Fig. 2.
3.1.2. Mass spectrometry
In the MS chart of NTZ, the parent peak was identiﬁed at m/z
307 (corresponding to the molecular weight of NTZ) while MS
chart of degradation product formed under acid stress condi-
tion shows parent peak at m/z 265 (corresponding to the
molecular weight of Deg I) and that of Deg II shows parent
peak at m/z 145, as shown in Fig. 3.
3.1.3. TLC-fractionation
TLC-monitoring of the drug degradation was done on thin
layer plates of silica gel F254 using chloroform–methanol–
ammonia solution–glacial acetic acid (95:5:1:1 by volume,
pH¼5.80) as a developing system. The developed plates were
visualized under short UV-lamp. Comparing the Rf of the two
degradation products that obtained from alkaline stress
Figure 6 Thin layer chromatogram of separated peaks of Deg III
(Rf¼0.03), Deg I (Rf¼0.13), Deg II (Rf¼0.37) and NTZ
(Rf¼0.72) using chloroform–methanol–ammonia solution–glacial
acetic acid (95:5:1:1 by volume, pH¼5.80) as a developing system
at 254 nm.
Figure 7 Thin layer chromatogram of nitazoxanide in the
Table 2 Parameters of system suitability of the developed
TLC-densitometric method for the determination of nita-
zoxanide in presence of its degradation products.
Parameters Deg III Deg I Deg II NTZ
Symmetry factor 1.01 0.98 1.05 1.02
Resolution (Rs) 1.21 2.57 4.55
Capacity factor (K0) 1.20 2.64 5.12 7.35
Selectivity (a) 2.04 2.46 4.77
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obtained after acidiﬁcation and extraction with ether is equal
to the Rf value of standard salicylic acid proving their
similarity.concentration range 0.4–2.0 mg/band (Rf¼0.72) using chloro-
form–methanol–ammonia solution–glacial acetic acid (95:5:1:1
by volume, pH¼5.80) as a developing system.3.2. First derivative of ratio spectra spectrophotometric
method (DD1)
Nitazoxanide and its degradation products (Deg I, Deg II and
Deg III) are highly absorbing substances in the UV region of
the spectrum, as shown in Fig. 4. On the basis of derivative
ratio theory, ﬁrst derivative of the ratio spectra technique was
applied to solve the problem of overlapping spectra of NTZ,
Deg I, Deg II and Deg III. The main advantage of the method
is that the whole spectrum of interfering substance is canceled.
Accordingly, the choice of the wavelength selected for calibra-
tion is not critical.
Selection of the divisor and its concentration is of great
importance, so Deg I, Deg II and Deg III in different
concentrations (5, 10, 15 and 20 mg/mL) were tried as divisors.
The best results in terms of signal to noise ratio, sensitivity and
selectivity followed using 5 mg/mL of Deg I as a divisor.
The absorption spectra of NTZ, Deg I, Deg II and Deg III
were divided by the spectrum of 5 mg/mL of Deg I (as a divisor),
and DD1 spectra were obtained, where NTZ could be deter-
mined at 364.4 nm (at which no contribution from Deg I, Deg II
and Deg III). Different smoothing factor (Dl) values were tried
where a smoothing factor¼4 gave the best resolution, different
scaling factor values were tested where scaling factor¼10 was
suitable to enlarge the signal of NTZ to facilitate its measure-
ment and to diminish error in reading signal.
Dividing the absorption spectra of NTZ in the range of
2–24 mg/mL by the absorption spectrum of 5 mg/mL of Deg I,
the obtained ratio spectra were differentiated with respect to
wavelength (Dl¼4, scaling factor¼10) and the interference
was eliminated, as shown in Fig. 5.DD1 values showed good linearity at 364.4 nm in the
concentration range of 2–24 mg/mL. The linear regression equa-
tion was found to be
A¼ 0:0480C þ 0:0010 r¼ 0:9999
where A is the peak amplitude at 364.4 nm, C is the concentra-
tion of NTZ in mg/mL and r is the correlation coefﬁcient.3.3. Chemometric methods
This method is based on UV-spectrophotometry, and the
resulting heavily overlapping responses are processed by
chemometrics. In this method, different chemometric
approaches were applied for simultaneous determination of
NTZ and its degradation products, including PCR and PLS
methods. These multivariate calibrations were useful in spec-
tral analysis because the simultaneous inclusion of many
spectral wavelengths instead of single wavelength greatly
improved the precision and predictive ability [29].
The ﬁrst step in the simultaneous determination of the
components by multivariate calibration methods involves
constructing the calibration matrix for quaternary mixture.
The calibration set was obtained using the absorption spectra
of a set of 21 mixtures of NTZ, Deg I, Deg II and Deg III with
different ratios of each component as given in Table 1. Better
results were obtained upon rejecting the spectral region above
360 nm and below 260 nm.
Table 3 Determination of nitazoxanide in laboratory prepared mixtures by ﬁrst derivative of ratio spectra spectrophotometric
method and TLC-densitometric method.
% Degradation
products
Concentration (NTZ: Deg I: Deg II: Deg III) Recovery of NTZa (%)
DD1 (mg/mL) TLC (mg/band) DD1 TLC
10 18:1:0.5:0.5 1.8:0.1:0.05:0.05 100.56 100.44
25 15:2.5:1.3:1.2 1.5:0.3:0.1:0.1 99.00 99.13
35 6.5:1.5:1:1 1.3:0.3:0.02:0.02 100.43 100.83
45 11:4.5:2.5:2 1.1:0.45:0.25:0.2 101.17 100.89
55 9:6:2.6:2.4 0.9:0.5:0.3:0.3 98.00 97.60
70 6:6.7:3.8:3.5 0.6:0.65:0.4:0.35 101.00 101.50
90 — 0.2:0.9:0.5:0.4 – 100.26
Mean7SD 100.0371.25 100.0971.32
Percent of the degradation products were calculated according to their molecular weight.
aAverage of 3 determinations.
Table 4 Results of determination of nitazoxanide, Deg I, Deg II and Deg III in the validation set using the proposed multivariate
calibration methods.
Mixture no. Recoverya (%)
NTZ Deg I Deg II Deg III
PCR PLS PCR PLS PCR PLS PCR PLS
1 100.14 100.11 101.34 101.33 98.32 98.50 102.43 102.05
2 101.43 101.30 102.25 102.20 96.71 96.83 100.78 100.71
3 99.54 99.65 100.78 100.73 98.38 98.43 99.64 99.75
4 97.87 97.91 101.41 101.40 102.34 101.88 101.63 101.6
5 100.63 100.61 100.69 100.67 100.86 100.82 102.59 102.33
6 98.93 98.95 98.35 98.36 99.46 99.46 103.15 102.88
7 100.53 100.50 99.52 99.52 98.61 98.65 96.80 97.25
8 99.10 99.16 101.06 101.05 103.10 103.04 98.47 98.47
9 98.23 98.25 102.17 102.11 102.77 102.80 99.31 99.35
10 97.79 97.82 100.78 100.77 101.31 101.30 98.32 98.33
11 100.58 100.50 97.75 97.75 97.58 97.75 97.40 97.47
12 101.34 101.26 96.78 96.91 103.23 102.86 102.88 102.75
Mean7SD 99.6871.29 99.6771.24 100.2471.76 100.2371.72 100.2272.32 100.1972.19 100.2872.25 100.2572.08
aAverage of 3 determinations.
N.W. Ali et al.112In this study, the ‘‘leave one out’’ cross validation method
was used and the RMSECV values of different developed
models were compared. Five factors were found suitable for
both PCR and PLS models. Table 1 shows different concen-
trations of NTZ, Deg I, Deg II and Deg III used in the
validation set.
For evaluation of the predictive abilities of the developed
models, several diagnostic tools were used: predictive versus
actual concentration plot (model and sample diagnostic);
concentration residuals versus actual concentration plot
(model and sample diagnostic) and root mean square error
of prediction (RMSEP) (model diagnostic), the predicted
concentrations of the validation samples were calculated.3.4. TLC-densitometric method
Chromatographic techniques overcome the problem of over-
lapping absorption spectra of mixture of drugs or in presenceof impurities or degradation products by separation of these
components on TLC plates or chromatographic columns and
determining each ingredient by scanning the corresponding
chromatogram [30]. It has many applications in the ﬁeld of
pharmaceutical studies, which include the following: stability,
impurities, synthetic drugs, pharmacokinetic, enantiomeric
purity and drug monitoring in biological ﬂuids [31,32].
To improve separation of bands, it was necessary to
investigate the effect of different parameters. These parameters
were studied and optimized to achieve maximum separation as
follows.3.4.1. Mobile phase
Initial experiments for the separation of NTZ and its
degradation products were performed using various propor-
tions of different solvent systems, which resulted in varying
retention factors, tailing of the peaks, larger run times, and
moreover improper resolution of the four components. Since
Table 5 Determination of nitazoxanide in pharmaceutical formulations by the proposed methods and application of standard addition technique.
Pharmaceutical
formulation
DD1 method Chemometric methods TLC-densitometric method
Taken
(mg/
mL)
Founda
7SD
(%)
Pure
added (mg/
mL)
Recoveryb
(%)
Mean
7SD
Taken
(mg/
mL)
Founda
7SD (%)
Pure
added (mg/
mL)
Recoveryb (%) Taken
(mg/
mL)
Founda
7SD
(%)
Pure
added (mg/
mL)
Recoveryb
(%)
Mean
7SD
PCR PLS PCR Mean
7SD
PLS Mean
7SD
Nit cleans
tablets
8.00 100.78
70.96
6.00 99.00 100.50
71.02
4.00 101.12
71.00
101.15
71.01
3.00 100.67 100.28
71.41
100.67 100.27
71.26
0.800 101.05
70.89
0.600 100.33 100.37
70.80
8.00 101.25 4.00 101.25 101.00 0.800 100.88
10.00 101.00 5.00 98.20 98.40 1.000 101.00
12.00 101.00 6.00 101.00 101.00 1.200 99.25
Nitazods oral
suspension
8.00 98.58
71.07
6.00 101.33 100.08
71.41
4.00 98.68
70.92
98.70
70.92
3.00 99.33 99.90
71.19
99.33 99.93
71.00
0.800 98.94
70.91
0.600 101.67 99.72
71.34
8.00 98.63 4.00 100.75 100.75 0.800 98.63
10.00 99.10 5.00 101.00 100.80 1.000 99.30
12.00 101.25 6.00 98.50 98.83 1.200 99.25
Cryptonazs oral
suspension
8.00 98.76
71.01
6.00 101.67 100.56
70.99
4.00 99.43
70.87
99.50
70.86
3.00 100.67 100.46
71.10
100.67 100.43
70.89
0.800 97.58
71.05
0.600 101.33 100.54
71.12
8.00 100.63 4.00 100.50 100.50 0.800 98.88
10.00 100.70 5.00 99.00 99.20 1.000 101.10
12.00 99.25 6.00 101.67 101.33 1.200 100.83
aAverage of 6 determinations.
bAverage of 3 determinations.
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Table 6 Assay parameters and method validation obtained by applying the proposed methods for the determination of
Nitazoxanide.
Parameters DD1
spectrophotometric
method
Chemometric methods TLC-densitometric
method
PCR PLS
Range 2–24 mg/mL 2–10 mg/mL 0.4–2.0 mg/band
Linearity
Slope 0.0480 0.9972 0.9973 2.2575
Intercept 0.0010 0.0017 0.0108 0.1262
Correlation coefﬁcient (r) 0.9999 0.9996 0.9997 0.9998
Accuracy (Mean7SD) 99.8570.75 99.6871.29 99.6771.24 100.0771.15
Speciﬁcity and selectivity 99.8871.21 – – 100.0771.44
Precision (%RSD)
Repeatabilitya 0.83 0.75 0.68 0.81
Intermediate precisionb 0.96 0.77 0.84 1.12
LODc 0.95 mg/mL 0.78 mg/mL 0.83 mg/mL 0.10 mg/band
aThe intraday (n¼3), average of three different concentrations repeated three times within day.
bThe interday (n¼3), average of three different concentrations repeated three times in three successive days.
cLimit of detection is determined experimentally for TLC-densitometric method and via calculations for the other methods.
N.W. Ali et al.114the components under investigation are weakly basic (NTZ
and Deg II) and weakly acidic (Deg I and Deg III) in nature,
addition of glacial acetic acid and ammonia solution in the
solvent mixture decreased tailing of the peaks and improved
the resolution of the components. Following several attempts
in order to develop an appropriate separation method, the
peaks ensued following the chromatographic scan were
sharp, symmetrical, reproducible and the base line resolution
was better with no disturbance upon using chloroform–
methanol–ammonia solution–glacial acetic acid (95:5:1:1 by
volume, pH¼5.80) as a developing system, as shown in
Fig. 6.
3.4.2. Band dimensions
While applying samples as bands, it should be taken into
consideration the slight spread of the developed bands due to
ordinary diffusion so the band width and the interspaces
between bands should be chosen carefully to avoid spread of
bands outside the scanning tracks and interference between
adjacent bands. Moreover, narrow band width should be
avoided to prevent overloading of silica especially if higher
volumes are applied, which lead ﬁnally to tailing and inaccu-
rate results. Accordingly, the optimum band width chosen was
6 mm and the interspace between bands was 5 mm.
3.4.3. Scanning wavelength
Different scanning wavelengths were tried, like 240, 254, 300
and 365 nm, where the wavelength 254 nm was the best
wavelength for detection of all components with good sensi-
tivity of NTZ in the same scan and peaks were sharp and
symmetrical and minimum noise was obtained.
3.4.4. Slit dimensions of scanning light beam
The slit dimensions of the scanning light beam should ensure
complete coverage of band dimensions on the scanned track
without interference of adjacent bands. Different slit dimen-
sions were tried, where 5 mm 0.2 mm proved to be the slitdimension of choice, which provides highest sensitivity
for NTZ.
3.4.5. System suitability
USP [33] states that system suitability tests are an integral part
of liquid chromatographic methods. They are used to verify
that the resolution and reproducibility of the chromatographic
system are adequate for the analysis to be done. Parameters
including resolution (Rs), peak symmetry, capacity factor (K
0)
and selectivity factor (a) were calculated using 1.0 mg/band of
NTZ. The resolution is always above two, the selectivity more
than one and an accepted value for symmetry factor was
obtained for NTZ, as shown in Table 2.
This method offers high sensitivity and selectivity for
analysis of NTZ in presence of its degradation products using
chloroform–methanol–ammonia solution–glacial acetic acid
(95:5:1:1 by volume, pH¼5.80) as a developing system, where
the good separation is obtained by the difference in the
retention factor (Rf) values of Deg III (Rf¼0.03), Deg I
(Rf¼0.13), Deg II (Rf¼0.37) and NTZ (Rf¼0.72) as shown in
Fig. 6.
The calibration curve was constructed relating the inte-
grated peak area and the corresponding concentrations of
NTZ in the range of 0.4–2.0 mg/band, as shown in Fig. 7. The
concentration of NTZ was calculated from the following
regression equation:
Y ¼ 2:2575C þ 0:1262 r¼ 0:9998
where Y is the integrated peak area ( 103), C is
the concentration in mg/band and r is the correlation
coefﬁcient.
3.5. Stability-indication
To assess the stability-indicating efﬁciency of the proposed
methods, they were applied to laboratory prepared mixtures
containing different ratios of NTZ, Deg I, Deg II and Deg III.
Table 7 Statistical comparison of the results obtained by the proposed methods and the reported method for the determination
of pure nitazoxanide.
Parameters DD1 spectrophotometric
method
Chemometric methods TLC-densitometric
method
Reported
methoda [23]
PCR PLS
Mean 99.85 99.68 99.67 100.07 99.90
SD 0.75 1.29 1.24 1.15 1.18
% RSD 0.75 1.29 1.24 1.15 1.18
n 6 12 12 6 8
Variance 0.56 1.66 1.54 1.32 1.39
Student’s t-test 0.09 (2.18) 0.31 (2.10) 0.34 (2.10) 0.23 (2.18)
F-value 2.48 (4.88) 1.19 (3.60) 1.11 (3.60) 1.05 (4.88)
Figures between parenthesis represent the corresponding tabulated values of t and F at P¼0.05.
aRP-HPLC using 0.1% phosphoric acid–acetonitrile (44:45, v/v) at pH¼6 with UV detection at 240 nm and ﬂow rate 1 mL/min.
Stability indicating methods for determination of nitazoxanide 115Results given in Table 3 indicate that the proposed DD1
method is valid for determination of intact NTZ in presence of
up to 70% of its degradation products and TLC-densitometric
method is selective and valid for determination of NTZ in
presence of up to 90% of its degradation products.
To validate the prediction ability of the suggested PCR and
PLS models, they were used to predict the concentration of NTZ
and its degradation products in laboratory prepared mixtures
containing their different ratios; satisfactory results were obtained
as shown in Table 4. Also, the chemometric methods allow the
determination of the degradation products’ concentrations.
As the suggested methods could effectively determine the
drug in presence of its degradation products, they can be
employed as stability indicating ones.
3.6. Application of the proposed methods to the
pharmaceutical formulations
The suggested methods were successfully applied for the deter-
mination of NTZ in its pharmaceutical formulations (Nit
Cleans tablets and Nitazods and Cryptonazs oral suspen-
sions), showing good percentage recoveries as given in Table 5.
The validity of the suggested methods was further assessed by
applying the standard addition technique as shown in Table 5.
3.7. Method validation
Method validation was performed according to ICH [24] guide-
lines for the proposed methods. Table 6 shows the results of
accuracy, repeatability and intermediate precision of the methods.
Other regression equation parameters are shown in Table 6, which
shows good linear relationship for the methods as revealed by the
correlation coefﬁcient. Results of assay validation parameters of
the proposed chemometric methods are demonstrated in Table 6,
where satisfactory correlation coefﬁcient (r) value was obtained for
NTZ in the validation set by PCR and PLS optimized models
indicating good predictive abilities of the models.
3.8. Statistical analysis
Results obtained by the suggested methods for determination
of NTZ were statistically compared with those obtained by
applying the reported HPLC method [23]. The calculatedt- and F-values [34] were found to be less than the theoretical
ones, conﬁrming accuracy and precision at 95% conﬁdence
level, as given in Table 7. The test ascertains that the proposed
methods are as precise and accurate as the reported HPLC
method [23] and are comparable to one another. The results
obtained indicate that the introduced methods can be classi-
ﬁed amongst the highly selective and sensitive procedures.
These merits suggest the use of the proposed methods in
routine and quality control analysis without interference of
commonly encountered pharmaceutical formulation additives.4. Conclusion
In the presented work, three different, simple, accurate and
economical stability indicating methods were suggested for
determination of NTZ. Moreover, the proposed methods were
found to be more selective than the reported HPLC method,
which showed severe overlapping between the drug and its
degradation products.
First derivative of ratio spectra spectrophotometric method
is well established technique that are able to enhance the
resolution of overlapping bands. This method is simple, more
convenient, less time consuming and economic stability indi-
cating method for determination of NTZ compared to other
published LC methods.
The advantage of multicomponent analysis using multi-
variate calibration is the speed of the proposed procedures, as
a separation step avoids. No data about the application of
chemometric methods have been found in the literature. It
offers a distinct possibility of assaying NTZ in its pharma-
ceutical formulations without interference due to the excipi-
ents or the degradation products and the method is capable of
determination of the degradation products concentration.
The advantage of TLC-densitometric method is that several
samples can be run simultaneously using a small quantity of
mobile phase, thus lowering analysis time and cost per analysis
and provides high sensitivity and selectivity.
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